drugset / Trial / NCT06518044
NAC for Hematopoietic Recovery in SAA
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective single-arm clinical study to evaluate the role of NAC among patients with severe aplastic anemia (SAA) can promote hematopoietic recovery after haploidentical transplantation.
Timeline
- Start
- 2024-07-25
- Primary completion
- 2024-12-31
- Completion
- 2025-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 400 mg | Oral |